AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Cost of goods sold

annual cost of goods sold:

$1.77B+$236.58M(+15.39%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMRX annual cost of goods sold is $1.77 billion, with the most recent change of +$236.58 million (+15.39%) on December 31, 2024.
  • During the last 3 years, AMRX annual cost of goods sold has risen by +$471.51 million (+36.21%).
  • AMRX annual cost of goods sold is now at all-time high.

Performance

AMRX Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly cost of goods sold:

$438.25M-$1.27M(-0.29%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX quarterly cost of goods sold is $438.25 million, with the most recent change of -$1.27 million (-0.29%) on June 30, 2025.
  • Over the past year, AMRX quarterly cost of goods sold has dropped by -$13.58 million (-3.01%).
  • AMRX quarterly cost of goods sold is now -6.28% below its all-time high of $467.64 million, reached on December 31, 2024.

Performance

AMRX quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM cost of goods sold:

$1.78B-$13.58M(-0.76%)
June 30, 2025

Summary

  • As of today (September 18, 2025), AMRX TTM cost of goods sold is $1.78 billion, with the most recent change of -$13.58 million (-0.76%) on June 30, 2025.
  • Over the past year, AMRX TTM cost of goods sold has increased by +$126.81 million (+7.68%).
  • AMRX TTM cost of goods sold is now -0.76% below its all-time high of $1.79 billion, reached on March 31, 2025.

Performance

AMRX TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

AMRX Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.4%-3.0%+7.7%
3 y3 years+36.2%+23.9%+31.3%
5 y5 years+54.6%+37.1%+51.4%

AMRX Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+36.2%-6.3%+25.0%-0.8%+31.3%
5 y5-yearat high+54.6%-6.3%+45.3%-0.8%+51.4%
alltimeall timeat high>+9999.0%-6.3%>+9999.0%-0.8%>+9999.0%

AMRX Cost of goods sold History

DateAnnualQuarterlyTTM
Jun 2025
-
$438.25M(-0.3%)
$1.78B(-0.8%)
Mar 2025
-
$439.53M(-6.0%)
$1.79B(+1.0%)
Dec 2024
$1.77B(+15.4%)
$467.64M(+8.0%)
$1.77B(+4.5%)
Sep 2024
-
$432.91M(-4.2%)
$1.70B(+2.7%)
Jun 2024
-
$451.83M(+7.3%)
$1.65B(+4.6%)
Mar 2024
-
$421.13M(+7.7%)
$1.58B(+2.7%)
Dec 2023
$1.54B(+8.5%)
$391.05M(+0.9%)
$1.54B(+0.1%)
Sep 2023
-
$387.51M(+2.2%)
$1.53B(+2.5%)
Jun 2023
-
$379.02M(-0.1%)
$1.50B(+1.7%)
Mar 2023
-
$379.35M(-2.5%)
$1.47B(+4.0%)
Dec 2022
$1.42B(+8.8%)
$389.05M(+10.9%)
$1.42B(+2.9%)
Sep 2022
-
$350.65M(-0.9%)
$1.38B(+1.6%)
Jun 2022
-
$353.72M(+9.5%)
$1.35B(+2.4%)
Mar 2022
-
$323.06M(-7.3%)
$1.32B(+1.7%)
Dec 2021
$1.30B(-2.1%)
$348.49M(+5.8%)
$1.30B(+0.4%)
Sep 2021
-
$329.39M(+2.1%)
$1.30B(-1.8%)
Jun 2021
-
$322.58M(+7.0%)
$1.32B(+0.2%)
Mar 2021
-
$301.54M(-12.1%)
$1.32B(-0.9%)
Dec 2020
$1.33B(+15.9%)
$342.96M(-2.9%)
$1.33B(+5.5%)
Sep 2020
-
$353.35M(+10.5%)
$1.26B(+7.3%)
Jun 2020
-
$319.67M(+1.9%)
$1.17B(+2.0%)
Mar 2020
-
$313.58M(+14.7%)
$1.15B(+0.3%)
Dec 2019
$1.15B(+22.4%)
$273.37M(+2.1%)
$1.15B(-2.5%)
Sep 2019
-
$267.72M(-9.7%)
$1.18B(-0.1%)
Jun 2019
-
$296.38M(-4.3%)
$1.18B(+5.5%)
Mar 2019
-
$309.74M(+2.3%)
$1.12B(+19.1%)
Dec 2018
$937.59M(+84.8%)
$302.92M(+12.8%)
$937.59M(+20.7%)
Sep 2018
-
$268.58M(+14.1%)
$776.62M(+23.7%)
Jun 2018
-
$235.49M(+80.3%)
$627.76M(+18.8%)
Mar 2018
-
$130.59M(-8.0%)
$528.40M(+32.8%)
Dec 2017
$507.48M(+10.4%)
$141.95M(+18.6%)
$397.81M(+3.4%)
Sep 2017
-
$119.72M(-12.1%)
$384.90M(-0.8%)
Jun 2017
-
$136.14M(>+9900.0%)
$388.16M(+10.9%)
Mar 2017
-
$0.00(-100.0%)
$350.13M(-25.8%)
Dec 2016
$459.80M(-9.5%)
-
-
Dec 2016
-
$129.05M(+4.9%)
$471.64M(-7.5%)
Sep 2016
-
$122.97M(+25.3%)
$509.92M(-0.4%)
Jun 2016
-
$98.11M(-19.3%)
$512.10M(-5.7%)
Mar 2016
-
$121.52M(-27.4%)
$543.32M(+7.4%)
Dec 2015
$508.06M(+81.1%)
$167.32M(+33.7%)
$505.67M(+23.7%)
Sep 2015
-
$125.15M(-3.2%)
$408.73M(+14.4%)
Jun 2015
-
$129.33M(+54.2%)
$357.14M(+16.7%)
Mar 2015
-
$83.86M(+19.1%)
$306.16M(+9.2%)
Dec 2014
$280.50M(-8.1%)
$70.39M(-4.3%)
$280.50M(+0.9%)
Sep 2014
-
$73.56M(-6.1%)
$277.93M(+0.9%)
Jun 2014
-
$78.35M(+34.6%)
$275.47M(+2.8%)
Mar 2014
-
$58.20M(-14.2%)
$267.86M(-10.8%)
Dec 2013
$305.17M(+2.0%)
$67.82M(-4.6%)
$300.28M(-2.9%)
Sep 2013
-
$71.10M(+0.5%)
$309.39M(+1.2%)
Jun 2013
-
$70.74M(-21.9%)
$305.85M(-5.5%)
Mar 2013
-
$90.62M(+17.8%)
$323.74M(+6.9%)
Dec 2012
$299.14M
$76.93M(+13.9%)
$302.86M(-1.4%)
Sep 2012
-
$67.56M(-23.8%)
$307.09M(+3.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
$88.64M(+27.1%)
$296.73M(+8.2%)
Mar 2012
-
$69.74M(-14.1%)
$274.25M(+7.7%)
Dec 2011
$254.62M(-25.2%)
$81.16M(+41.9%)
$254.62M(+14.6%)
Sep 2011
-
$57.20M(-13.5%)
$222.12M(-27.9%)
Jun 2011
-
$66.16M(+32.0%)
$308.05M(-0.9%)
Mar 2011
-
$50.11M(+3.0%)
$310.79M(-8.7%)
Dec 2010
$340.25M(+99.8%)
$48.66M(-66.0%)
$340.25M(-10.5%)
Sep 2010
-
$143.12M(+107.7%)
$380.31M(+43.4%)
Jun 2010
-
$68.89M(-13.4%)
$265.25M(+18.6%)
Mar 2010
-
$79.58M(-10.3%)
$223.64M(+31.3%)
Dec 2009
$170.31M(+85.2%)
$88.72M(+216.3%)
$170.31M(+54.8%)
Sep 2009
-
$28.05M(+2.8%)
$110.00M(+5.5%)
Jun 2009
-
$27.28M(+3.9%)
$104.24M(+6.7%)
Mar 2009
-
$26.25M(-7.6%)
$97.66M(+3.0%)
Dec 2008
$91.97M(-14.6%)
$28.41M(+27.4%)
$94.79M(-5.0%)
Sep 2008
-
$22.30M(+7.7%)
$99.75M(-3.6%)
Jun 2008
-
$20.70M(-11.4%)
$103.45M(-6.8%)
Mar 2008
-
$23.38M(-30.0%)
$111.05M(+3.1%)
Dec 2007
$107.66M(+49.0%)
$33.38M(+28.4%)
$107.66M(+14.5%)
Sep 2007
-
$25.99M(-8.2%)
$94.00M(+10.6%)
Jun 2007
-
$28.30M(+41.6%)
$85.02M(+12.0%)
Mar 2007
-
$19.99M(+1.4%)
$75.92M(+5.1%)
Dec 2006
$72.25M(+23.6%)
$19.72M(+15.9%)
$72.25M(+37.5%)
Sep 2006
-
$17.01M(-11.4%)
$52.53M(+47.9%)
Jun 2006
-
$19.20M(+17.7%)
$35.52M(+117.7%)
Mar 2006
-
$16.32M(-7.2%)
$16.32M(-76.0%)
Dec 2005
$58.44M(+41.1%)
-
-
Sep 2004
-
$17.59M(-5.1%)
$68.00M(+7.3%)
Jun 2004
-
$18.54M(-0.1%)
$63.39M(+17.0%)
Mar 2004
-
$18.55M(+39.2%)
$54.17M(+23.8%)
Dec 2003
$41.40M(+123.9%)
$13.32M(+2.7%)
$43.77M(+16.4%)
Sep 2003
-
$12.98M(+39.2%)
$37.60M(+26.3%)
Jun 2003
-
$9.32M(+14.4%)
$29.77M(+21.9%)
Mar 2003
-
$8.15M(+13.9%)
$24.43M(+25.2%)
Dec 2002
$18.49M(+36.4%)
$7.15M(+38.8%)
$19.52M(+18.3%)
Sep 2002
-
$5.15M(+29.4%)
$16.50M(+13.3%)
Jun 2002
-
$3.98M(+23.1%)
$14.56M(+7.5%)
Mar 2002
-
$3.23M(-21.7%)
$13.54M(-0.1%)
Dec 2001
$13.56M(-5.3%)
$4.13M(+28.4%)
$13.56M(+1.8%)
Sep 2001
-
$3.22M(+8.5%)
$13.32M(-6.0%)
Jun 2001
-
$2.96M(-8.7%)
$14.18M(-5.8%)
Mar 2001
-
$3.25M(-16.5%)
$15.04M(+0.3%)
Dec 2000
$14.32M(+1448.1%)
$3.89M(-4.4%)
$15.01M(+35.0%)
Sep 2000
-
$4.07M(+6.2%)
$11.11M(+26.5%)
Jun 2000
-
$3.83M(+19.4%)
$8.79M(+28.5%)
Mar 2000
-
$3.21M(+84.1%)
$6.84M(+37.8%)
Dec 1999
$925.00K(-80.2%)
-
-
Sep 1999
-
$1.74M(-7.5%)
$4.96M(+14.0%)
Jun 1999
-
$1.89M(+41.2%)
$4.35M(+22.1%)
Mar 1999
-
$1.33M(+17.7%)
$3.57M(+5.3%)
Dec 1998
$4.68M
-
-
Sep 1998
-
$1.13M(+3.3%)
$3.39M(+50.3%)
Jun 1998
-
$1.10M(-5.1%)
$2.25M(+94.9%)
Mar 1998
-
$1.16M
$1.16M

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual cost of goods sold?

The current annual cost of goods sold of AMRX is $1.77B

What is the all time high annual cost of goods sold for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual cost of goods sold is $1.77B

What is Amneal Pharmaceuticals, Inc. annual cost of goods sold year-on-year change?

Over the past year, AMRX annual cost of goods sold has changed by +$236.58M (+15.39%)

What is Amneal Pharmaceuticals, Inc. quarterly cost of goods sold?

The current quarterly cost of goods sold of AMRX is $438.25M

What is the all time high quarterly cost of goods sold for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly cost of goods sold is $467.64M

What is Amneal Pharmaceuticals, Inc. quarterly cost of goods sold year-on-year change?

Over the past year, AMRX quarterly cost of goods sold has changed by -$13.58M (-3.01%)

What is Amneal Pharmaceuticals, Inc. TTM cost of goods sold?

The current TTM cost of goods sold of AMRX is $1.78B

What is the all time high TTM cost of goods sold for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM cost of goods sold is $1.79B

What is Amneal Pharmaceuticals, Inc. TTM cost of goods sold year-on-year change?

Over the past year, AMRX TTM cost of goods sold has changed by +$126.81M (+7.68%)
On this page